Literature DB >> 4055761

Purification and characterization of multiple isoforms of tropomyosin from rat cultured cells.

F Matsumura, S Yamashiro-Matsumura.   

Abstract

We have previously shown that rat cultured cells contain five isoforms of tropomyosin (Matsumura, F., Yamashiro-Matsumura, S., and Lin, J. J.-C. (1983) J. Biol. Chem. 258, 6636-6644) and that these tropomyosins are differentially expressed upon cell transformation (Matsumura, F., Lin, J. J.-C., Yamashiro-Matsumura, S., Thomas, G. P., and Topp, W. C. (1983) J. Biol. Chem. 258, 13954-13964). To examine functions of tropomyosin in microfilament organization, we have purified and partially separated the multiple isoforms of tropomyosin by chromatography on hydroxylapatite. Analyses of cross-linked dimers produced by air oxidation have revealed that all isoforms except the tropomyosin isoform with apparent Mr of 35,000 form homodimers. Although these tropomyosins share many properties characteristic of tropomyosin, structural analyses at a peptide level and immunological analyses have shown that the five isoforms can be classified into two groups, i.e. tropomyosins with higher apparent Mr (Mr = 40,000, 36,500, and 35,000) and tropomyosins with lower apparent Mr (Mr = 32,400 and 32,000). The low Mr tropomyosins show less ability for head-to-tail polymerization and lower affinity to actin than the high Mr tropomyosins. We suggest that these differences in properties may be related to the changes in microfilament organization observed in transformed cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055761

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

2.  Restricted expression of the actin-regulatory protein, tropomyosin, defines distinct boundaries, evaginating neuroepithelium, and choroid plexus forerunners during early CNS development.

Authors:  K Nicholson-Flynn; S E Hitchcock-DeGregori; P Levitt
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

3.  Transformation-related expression of a low-molecular-mass tropomyosin isoform TM5/TM30nm in transformed rat fibroblastic cell lines.

Authors:  K Miyado; M Sato; S Taniguchi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Cloning and characterization of a cDNA encoding transformation-sensitive tropomyosin isoform 3 from tumorigenic human fibroblasts.

Authors:  C S Lin; J Leavitt
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

5.  Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells.

Authors:  K Takenaga; Y Nakamura; S Sakiyama
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

6.  Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly.

Authors:  M Gimona; A Watakabe; D M Helfman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.

Authors:  P G Galloway; P Mulvihill; S Siedlak; M Mijares; M Kawai; H Padget; R Kim; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

8.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.

Authors:  J Leavitt; S Y Ng; U Aebi; M Varma; G Latter; S Burbeck; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

9.  Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state.

Authors:  J Leavitt; S Y Ng; M Varma; G Latter; S Burbeck; P Gunning; L Kedes
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

10.  Tropomyosin isoform switching in tumorigenic human fibroblasts.

Authors:  J Leavitt; G Latter; L Lutomski; D Goldstein; S Burbeck
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.